[Editors' Choice] PARP inhibitors unleash the antitumor immune response
Combination of a PARP inhibitor with immune checkpoint blockade showed promising antitumor activity without additional toxicity.
Source: Science Translational Medicine - Category: Biomedical Science Authors: Ileana-Dumbrava, E. Tags: Editors ' Choice Source Type: research